Generation of hypoallergenic neoglycoconjugates for dendritic cell targeted vaccination: A novel tool for specific immunotherapy
Open Access
- 28 January 2013
- journal article
- Published by Elsevier BV in Journal of Controlled Release
- Vol. 165 (2), 101-109
- https://doi.org/10.1016/j.jconrel.2012.11.002
Abstract
No abstract availableFunding Information
- Austrian Science Fund (#W1213)
- Christian Doppler Research Association
- Biomay AG, Vienna, Austria
This publication has 52 references indexed in Scilit:
- Sequential class switching is required for the generation of high affinity IgE antibodiesThe Journal of Experimental Medicine, 2012
- Immature B cells preferentially switch to IgE with increased direct Sμ to Sε recombinationThe Journal of Experimental Medicine, 2011
- CD200R surface expression as a marker of murine basophil activationClinical & Experimental Allergy, 2009
- Effect of financial incentives on inequalities in the delivery of primary clinical care in England: analysis of clinical activity indicators for the quality and outcomes frameworkThe Lancet, 2008
- Socioeconomic factors and asthma control in childrenPediatric Pulmonology, 2008
- Effects of protein aggregates: An immunologic perspectiveThe AAPS Journal, 2006
- Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti–DC-SIGN antibodyBlood, 2005
- The skin prick test: “more than meets the eye”Annals of Allergy, Asthma & Immunology, 2004
- C-type lectin-like domainsCurrent Opinion in Structural Biology, 1999
- The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cellsEuropean Journal of Immunology, 1997